MTC Awards $2.2 Million in the January 2024 Investment Cycle - Missouri Technology Corporation

In January 2024, a total of $2.2 million was approved for equity-based investments in the following companies: Azome Therapeutics Inc is an early-stage drug discovery company focused on developing...